Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer
Open Access
- 24 March 2022
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 32 (9) , 6444-6455
Abstract
Objectives: To evaluate the interobserver agreement for MRI–based 2018 International Federation of Gynecology and Obstetrics (FIGO) staging parameters in patients with cervical cancer and assess the prognostic value of these MRI parameters in relation to other clinicopathological markers. Methods: This retrospective study included 416 women with histologically confirmed cervical cancer who underwent pretreatment pelvic MRI from May 2002 to December 2017. Three radiologists independently recorded MRI–derived staging parameters incorporated in the 2018 FIGO staging system. Kappa coefficients (κ) for interobserver agreement were calculated. The predictive and prognostic values of the MRI parameters were explored using ROC analyses and Kaplan–Meier with log-rank tests, and analyzed in relation to clinicopathological patient characteristics. Results: Overall agreement was substantial for the staging parameters: tumor size > 2 cm (κ = 0.80), tumor size > 4 cm (κ = 0.76), tumor size categories (≤ 2 cm; > 2 and ≤ 4 cm; > 4 cm) (κ = 0.78), parametrial invasion (κ = 0.63), vaginal invasion (κ = 0.61), and enlarged lymph nodes (κ = 0.63). Higher MRI–derived tumor size category (≤ 2 cm; > 2 and ≤ 4 cm; > 4 cm) was associated with a stepwise reduction in survival (p ≤ 0.001 for all). Tumor size > 4 cm and parametrial invasion at MRI were associated with aggressive clinicopathological features, and the incorporation of these MRI–based staging parameters improved risk stratification when compared to corresponding clinical assessments alone. Conclusion: The interobserver agreement for central MRI–derived 2018 FIGO staging parameters was substantial. MRI improved the identification of patients with aggressive clinicopathological features and poor survival, demonstrating the potential impact of MRI enabling better prognostication and treatment tailoring in cervical cancer. Key Points: • The overall interobserver agreement was substantial (κ values 0.61–0.80) for central MRI staging parameters in the 2018 FIGO system. • Higher MRI–derived tumor size category was linked to a stepwise reduction in survival (p ≤ 0.001 for all). • MRI–derived tumor size > 4 cm and parametrial invasion were associated with aggressive clinicopathological features, and the incorporation of these MRI–derived staging parameters improved risk stratification when compared to clinical assessments alone.Keywords
Funding Information
- Helse Vest (F-12168)
- Norges Forskningsråd (311350)
- Trond Mohn stiftelse (BFS2018TMT06)
This publication has 34 references indexed in Scilit:
- Parametrial Invasion in Cervical Cancer: Fused T2-weighted Imaging and High-b-Value Diffusion-weighted Imaging with Background Body Signal Suppression at 3 TRadiology, 2015
- The Role of Magnetic Resonance Imaging in Pretreatment Evaluation of Early-Stage Cervical CancerInternational Journal of Gynecological Cancer, 2014
- Estimating and comparing time‐dependent areas under receiver operating characteristic curves for censored event times with competing risksStatistics in Medicine, 2013
- Impact of tumor size on survival in cancer of the cervix and validation of stage IIA1 and IIA2 subdivisionsGynecologic Oncology, 2013
- Interobserver Variability of the International Federation of Gynecology and Obstetrics Staging in Cervical CancerInternational Journal of Gynecological Cancer, 2013
- Uterine cervical carcinoma: a comparison of two- and three-dimensional T2-weighted turbo spin-echo MR imaging at 3.0 T for image quality and local-regional stagingEuropean Radiology, 2012
- Consensus Interpretation in Imaging Research: Is There a Better Way?Radiology, 2010
- Parametrial Involvement in Radical Hysterectomy Specimens for Women With Early-Stage Cervical CancerObstetrics & Gynecology, 2009
- Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup studyGynecologic Oncology, 2009
- Staging of carcinoma of the uterine cervix and endometriumEuropean Radiology, 2007